Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 07, 2020

SELL
$30.35 - $67.14 $23,248 - $51,429
-766 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$55.65 - $79.83 $5,119 - $7,344
92 Added 13.65%
766 $47,000
Q3 2019

Nov 13, 2019

SELL
$64.7 - $85.39 $9,640 - $12,723
-149 Reduced 18.1%
674 $49,000
Q2 2019

Aug 15, 2019

BUY
$67.77 - $82.2 $5,895 - $7,151
87 Added 11.82%
823 $55,000
Q4 2018

Jan 28, 2019

SELL
$41.17 - $56.44 $3,581 - $4,910
-87 Reduced 10.57%
736 $33,000
Q1 2018

May 16, 2018

BUY
$56.98 - $72.41 $11,054 - $14,047
194 Added 30.84%
823 $48,000
Q4 2017

May 18, 2018

SELL
$53.3 - $74.56 $657,562 - $919,846
-12,337 Reduced 95.15%
629 $56,000
Q4 2017

Mar 07, 2018

BUY
$53.3 - $74.56 $691,087 - $966,744
12,966
12,966 $1.98 Million

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $1.04B
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Private Capital Group, LLC Portfolio

Follow Private Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Capital Group, LLC with notifications on news.